IS3Q:XETRA:XETRA-iShares MSCI World Quality Factor UCITS (EUR)

ETF | Others |

Last Closing

USD 63.38

Change

0.00 (0.00)%

Market Cap

USD 3.67B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.01 (-0.02%)

USD 420.85B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.01 (-0.08%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.03 (+0.09%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.02 (-0.07%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.09 (+0.35%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.13 (-0.29%)

USD 102.32B
8R80:XETRA Amundi Index Solutions - Amund..

+0.18 (+0.13%)

USD 102.11B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.06 (-0.12%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.50 (-0.50%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.84 (-0.32%)

USD 80.38B

ETFs Containing IS3Q:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.05% 91% A- 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.05% 91% A- 88% B+
Trailing 12 Months  
Capital Gain 23.57% 88% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.57% 88% B+ 86% B+
Trailing 5 Years  
Capital Gain 89.28% 91% A- 89% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 89.28% 91% A- 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 13.85% N/A N/A 81% B-
Dividend Return 13.85% N/A N/A 80% B-
Total Return N/A N/A N/A 84% B
Risk Return Profile  
Volatility (Standard Deviation) 14.40% N/A N/A 51% F
Risk Adjusted Return 96.18% N/A N/A 95% A
Market Capitalization 3.67B 93% A 83% B

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike